AI executive action stalled by White House infighting

"Administration officials had to walk back one of their own suggesting safety reviews like an "FDA for AI" - a sign of a lack of cohesion about what the government should do next."

"After National Economic Council Director Kevin Hassett said the White House was studying how "future AIs" may go through a process "just like an FDA drug," other officials were quick to tamp down his remarks, including White House chief of staff Susie Wiles and former AI and crypto czar David Sacks."

""The real issue is not what the American labs do, it's the fact that Chinese models and other models that other actors could train are going to have advanced cyber capabilities within the next six months or so, and so we need to take steps now to harden our systems," Sacks, who currently co-chairs the President's Council of Advisors on Science and Technology, told Fox Business this week."

"Hassett later told CNBC that "nobody has an idea that we should do something like bring in a giant new bureaucracy to approve AIs.""

Government leaders are concerned about the capabilities of leading AI labs’ latest models, but immediate federal action is being slowed by Washington realities. AI policy is expected to be on the agenda for Trump’s trip to Beijing, and industry is awaiting guidance after the release of frontier models. One industry source says the administration may wait for outcomes from the China summit before making final decisions. European governments are also seeking access to models such as Mythos for security testing. Administration officials have shown internal disagreement, including walking back earlier remarks about an “FDA for AI.” Hassett compared future AIs to FDA drug review processes, while other officials emphasized hardening systems against advanced cyber capabilities from Chinese and other models.

Read at Axios